Disease-modifying treatment with I(2) imidazoline receptor ligand LSL60101 in an Alzheimer's disease mouse model: a comparative study with donepezil.
Br J Pharmacol 2021
May 24. Disease-modifying treatment with I(2) imidazoline receptor ligand LSL60101 in an Alzheimer's disease mouse model: a comparative study with donepezil. Vasilopoulou F(1), Rodríguez-Arévalo S(2), Bagán A(2), Escolano C(2), Griñán-Ferré C(1), Pallàs M(1).